COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

•A MS patient treated with ocrelizumab healed from COVID-19 without consequences•Immunosuppression might have played favorable role•This report supports the use of immunosuppressants in serious COVID-19 c Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the wo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Multiple sclerosis and related disorders Ročník 42; s. 102120
Hlavní autoři:	Novi, Giovanni, Mikulska, Malgorzata, Briano, Federica, Toscanini, Federica, Tazza, Francesco, Uccelli, Antonio, Inglese, Matilde
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 01.07.2020
Témata:	Antibodies, Monoclonal, Humanized - therapeutic use Betacoronavirus Case Report Coronavirus Infections - complications Coronavirus Infections - physiopathology COVID-19 Humans Immunologic Factors - therapeutic use Male Middle Aged Multiple Sclerosis, Chronic Progressive - complications Multiple Sclerosis, Chronic Progressive - drug therapy Neurology Pandemics Pneumonia, Viral - complications Pneumonia, Viral - physiopathology Protective Factors SARS-CoV-2 Severity of Illness Index
ISSN:	2211-0348, 2211-0356, 2211-0356
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!